Case Study: a large biotech organization achieves 33% trial cost savings with CRIO

How Sponsors Can Leverage New Technologies To Lower Trial Costs

The case study examines a large biotech organization that sought to lower its clinical trial costs. The company traditionally relied on full-service contract research organizations (CROs) and their recommended vendors. To find a more efficient and cost-effective operating model, the organization was introduced to the CRIO platform, specifically its eSource and Reviewer solutions.

CRIO implemented its Direct Data Capture (DDC) system, which combines eSource with EDC. This model eliminated the need for source data transcription and enabled remote monitoring, which significantly increased monitor productivity. By adopting the CRIO solution, the large biotech organization achieved substantial savings. A detailed cost comparison for a hypothetical Phase 2 study projected a 33% reduction in monitoring and data management costs, resulting in total savings of over $1.1 million.